Dr. Felix Ratjen is a Paediatric Respirologist in the Division of Respiratory Medicine at The Hospital for Sick Children (SickKids) and Professor of Paediatrics at the University of Toronto. He is also Program Head and Senior Scientist in the Translational Medicine research program at SickKids Research Institute and co-leads the SickKids CF Centre. Dr. Ratjen conducts multiple clinical trials addressing cystic fibrosis lung disease including new therapeutic strategies to target the underlying defect, treatment of airway infections such as first infection with Pseudomonas aeruginosa, airway inflammation and other important aspects of the disease. In addition, he is involved in developing and validating new outcome measures to quantify important aspects of CF lung disease that can be utilized in clinical trials. He also studies other lung diseases and over the recent years has developed an interest in the clinical evaluation of Hereditary Hemorrhagic Telangiectasia (HHT), for which he is leading one of the largest dedicated paediatric clinics. <\/p>\n","protected":false},"excerpt":{"rendered":"
Dr. Felix Ratjen is a Paediatric Respirologist in the Division of Respiratory Medicine at The Hospital for Sick Children (SickKids) and Professor of Paediatrics at the University of Toronto. He is also Program Head and Senior Scientist in the Translational Medicine research program at SickKids Research Institute and co-leads the SickKids CF Centre. Dr. Ratjen […]<\/p>\n","protected":false},"author":1,"featured_media":2089,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-2088","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-speaker"],"yoast_head":"\n